| Outcome Measures: |
Primary: Changes of HbA1c from the baseline, 24 weeks | Secondary: Patients achieving HbA1c levels below 7%, N and percentage of the patients, 24 weeks|Changes of body fat (whole body fat, abdominal fat), kg, %; measured with bioelectrical impedance analysis, 24 weeks|Changes of body weight, 12 weeks, 24 weeks|Changes of glucose levels (fasting, 2-hour postprandial), mg/dL, 12 weeks, 24 weeks|Changes of systolic/diastolic blood pressures, mmHg, 12 weeks, 24 weeks|Changes of lipids (total cholesterol, HDLc, low density lipoprotein cholesterol [LDLc], triglycerides), mg/dL, 12 weeks, 24 weeks|Changes of electrolytes (uric acid), mg/dL, 12 weeks, 24 weeks|Changes in parathyroid hormone, pg/mL, 12 weeks, 24 weeks|Changes in 25-hydroxyl vitamin D3, ng/mL, 12 weeks, 24 weeks|Changes of albuminuria, mg/g, 12 weeks, 24 weeks|Changes of urine electrolytes (Na, K, Cl, Ca, P, glucose), mg/dL, 12 weeks, 24 weeks|Changes in ketone body, umol/L, 12 weeks, 24 weeks|Changes of carotid intima-media thickness, maximal thickness (mm), 24 weeks
|
